Results 151 to 160 of about 39,210 (216)

Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity. [PDF]

Cureus
Fernandes IV, Melo S, Sousa GM, Pazos MI, Lima C.   +4 more
europepmc   +1 more source

Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer. [PDF]

Target Oncol
Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Hamilton E, HER2CLIMB-05 Investigators.   +20 more
europepmc   +1 more source

Left inferior vena cava - when an anatomical variation has surgical implications. [PDF]

BMJ Case Rep
Palmeira B, Gomes M, Teixeira M, Pires M.   +3 more
europepmc   +1 more source

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial. [PDF]

Clin Cancer Res
Waks AG, Segui E, Li T, Lipsyc-Sharf M, Kallfelz E, DiLullo M, Patel A, Rahman T, Junkins K, Rahee H, Frey AM, Kelly E, Stalteri M, Wrabel E, Williams A, Parsons HA, Poorvu PD, Partridge AH, Abravanel DL, Poorvu N, LeStage B, Sicinski P, Tolaney SM, Wagle N, Tayob N, Shapiro GI.   +25 more
europepmc   +1 more source

Correction to "Validation of on-slide immunocytochemistry controls prepared from long-term preserved prefixed cell suspensions". [PDF]

Cancer Cytopathol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncologia

Marita de Novais Costa Salles de Almeida, Ana Carolina Lima Barros, Letícia Guimarães da Fonseca Dias, Sara Amorim Gandra   +3 more
  +9 more sources